EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

RNA sequencing of single allergen‐specific memory B cells after grass pollen immunotherapy: Two unique cell fates and CD29 as a biomarker for treatment effect

Craig I McKenzie iD, Nirupama Varese iD, Pei Mun Aui iD, Simone Reinwald iD, Bruce D Wines iD, P Mark Hogarth iD, Francis Thien iD, Mark Hew iD, Jennifer M Rolland iD, Robyn E O'Hehir iD, Menno C van Zelm iD

Allergy · 2023-03 · 78 (3) · 822-835

DOI: 10.1111/all.15529 ↗

At a glance

Journal article in Allergy, 2022-10. Written by Craig I McKenzie and 10 co-authors. Institution: Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Victoria, Australia. Major MEDLINE topics: Rhinitis, Allergic, Seasonal, Hypersensitivity, Lolium. Cited 43 times so far (Crossref); 50 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Health and Medical Research Council.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Sublingual immunotherapy (SLIT) for grass pollen allergy can modify the natural history of allergic rhinitis and is associated with increased allergen‐specific IgG 4 . IgG 4 competitively inhibits functional IgE on the surface of effector cells, such as mast cells and basophils, from binding to allergens. To further understand the important role memory B‐cell (Bmem) responses play in mediating the beneficial effects of SLIT, we assessed changes in allergen‐specific Bmem subsets induced by SLIT for grass pollen allergy.

Methods

Blood samples were collected twice outside the pollen season from twenty‐seven patients with sensitization to ryegrass pollen (RGP; Lolium perenne ) and seasonal rhinoconjunctivitis. Thirteen received 4‐month pre‐seasonal SLIT for grass pollen allergy, and 14 received standard pharmacotherapy only. Single‐cell RNA sequencing was performed on FACS‐purified Lol p 1‐specific Bmem before and after SLIT from four patients, and significant genes were validated by flow cytometry on the total cohort.

Results

Four months of SLIT increased RGP‐specific IgE and IgG 4 in serum and induced two Lol p 1‐specific Bmem subsets with unique transcriptional profiles. Both subsets had upregulated expression of beta 1 integrin ITGB1 (CD29), whereas IGHE (IgE), IGHG4 (IgG 4 ), FCER2 (CD23), and IL13RA1 were upregulated in one subset. There was an increase in the proportion of Lol p 1 + Bmem expressing surface IgG 4 , CD23, and CD29 after SLIT.

Conclusions

A clinically successful 4 months course of SLIT for grass pollen allergy induces two transcriptionally unique Bmem fates. Associated changes in surface‐expressed proteins on these Bmem subsets can be used as early biomarkers for treatment effects.

Subjects

MeSH terms (MEDLINE)

Rhinitis, Allergic, SeasonalHypersensitivityLoliumHumansAllergensMemory B CellsDesensitization, ImmunologicImmunoglobulin EPollenImmunoglobulin GBiomarkersSequence Analysis, RNAPoaceae

Author keywords

allergen immunotherapybiomarkersgrass pollen allergymemory B cellstranscriptomics

Substances

AllergensImmunoglobulin EImmunoglobulin GBiomarkers

Authors and institutions

  • Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Department of Allergy, Immunology and Respiratory Medicine, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Immune Therapies Group, Burnet Institute, Melbourne, Victoria, Australia.
  • Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia.
  • Respiratory Medicine, Eastern Health, Box Hill and Monash University, Melbourne, Victoria, Australia.
  • School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

ORCID profiles: Craig I McKenzie, Nirupama Varese, Pei Mun Aui, Simone Reinwald, Bruce D Wines, P Mark Hogarth, Francis Thien, Mark Hew, Jennifer M Rolland, Robyn E O'Hehir, Menno C van Zelm

Funding

  • National Health and Medical Research Council

Cite

APA

McKenzie, C. I., Varese, N., Aui, P. M., Reinwald, S., Wines, B. D., Hogarth, P. M., Thien, F., Hew, M., Rolland, J. M., O'Hehir, R. E., & van Zelm, M. C. (2023). RNA sequencing of single allergen‐specific memory B cells after grass pollen immunotherapy: Two unique cell fates and CD29 as a biomarker for treatment effect. Allergy, 78(3), 822-835. https://doi.org/10.1111/all.15529

Vancouver

McKenzie CI, Varese N, Aui PM, Reinwald S, Wines BD, Hogarth PM, et al. RNA sequencing of single allergen‐specific memory B cells after grass pollen immunotherapy: Two unique cell fates and CD29 as a biomarker for treatment effect. Allergy. 2023;78(3):822-835. doi:10.1111/all.15529

BibTeX
@article{McKenzie2023,
  author = {McKenzie, Craig I and Varese, Nirupama and Aui, Pei Mun and Reinwald, Simone and Wines, Bruce D and Hogarth, P Mark and Thien, Francis and Hew, Mark and Rolland, Jennifer M and O'Hehir, Robyn E and van Zelm, Menno C},
  title = {RNA sequencing of single allergen‐specific memory B cells after grass pollen immunotherapy: Two unique cell fates and CD29 as a biomarker for treatment effect},
  journal = {Allergy},
  year = {2023},
  volume = {78},
  number = {3},
  pages = {822--835},
  doi = {10.1111/all.15529}
}
Start for free →